Global Immuno-Oncology Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Immuno-Oncology market will register a 15.5%% CAGR in terms of revenue, the global market size will reach $ 56450 million by 2025, from $ 31750 million in 2019. In particular, this report presents the global revenue market share of key companies in Immuno-Oncology business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-Oncology market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Immuno-Oncology, covering the supply chain analysis, impact assessment to the Immuno-Oncology market size growth rate in several scenarios, and the measures to be undertaken by Immuno-Oncology companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Hospitals
Drugstores
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bristol-Myers Squibb
Merck & Co., Inc.
AstraZeneca, Plc
Sanofi S.A.
Roche AG
Gilead Sciences Inc.
Dendreon Pharmaceuticals
Merck KGaA
Novartis
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Immuno-Oncology market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Immuno-Oncology market by identifying its various subsegments.
Focuses on the key global Immuno-Oncology players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Immuno-Oncology with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Immuno-Oncology submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immuno-Oncology Market Size 2015-2025
2.1.2 Immuno-Oncology Market Size CAGR by Region
2.2 Immuno-Oncology Segment by Type
2.2.1 Immune Checkpoint Inhibitors
2.2.2 Immune Checkpoint Inhibitors
2.2.3 Cancer Vaccines
2.2.4 CAR-T Cell Therapy
2.2.5 Others
2.3 Immuno-Oncology Market Size by Type
2.3.1 Global Immuno-Oncology Market Size Market Share by Type (2015-2020)
2.3.2 Global Immuno-Oncology Market Size Growth Rate by Type (2015-2020)
2.4 Immuno-Oncology Segment by Application
2.4.1 Hospitals
2.4.2 Drugstores
2.4.3 Others
2.5 Immuno-Oncology Market Size by Application
2.5.1 Global Immuno-Oncology Market Size Market Share by Application (2015-2020)
2.5.2 Global Immuno-Oncology Market Size Growth Rate by Application (2015-2020)
3 Global Immuno-Oncology by Players
3.1 Global Immuno-Oncology Market Size Market Share by Players
3.1.1 Global Immuno-Oncology Market Size by Players (2018-2020)
3.1.2 Global Immuno-Oncology Market Size Market Share by Players (2018-2020)
3.2 Global Immuno-Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Immuno-Oncology by Regions
4.1 Immuno-Oncology Market Size by Regions
4.2 Americas Immuno-Oncology Market Size Growth
4.3 APAC Immuno-Oncology Market Size Growth
4.4 Europe Immuno-Oncology Market Size Growth
4.5 Middle East & Africa Immuno-Oncology Market Size Growth
5 Americas
5.1 Americas Immuno-Oncology Market Size by Countries
5.2 Americas Immuno-Oncology Market Size by Type
5.3 Americas Immuno-Oncology Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Immuno-Oncology Market Size by Regions
6.2 APAC Immuno-Oncology Market Size by Type
6.3 APAC Immuno-Oncology Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Immuno-Oncology by Countries
7.2 Europe Immuno-Oncology Market Size by Type
7.3 Europe Immuno-Oncology Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Immuno-Oncology by Countries
8.2 Middle East & Africa Immuno-Oncology Market Size by Type
8.3 Middle East & Africa Immuno-Oncology Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Immuno-Oncology Market Forecast
10.1 Global Immuno-Oncology Market Size Forecast (2021-2025)
10.2 Global Immuno-Oncology Forecast by Regions
10.2.1 Global Immuno-Oncology Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Immuno-Oncology Forecast by Type
10.8 Global Immuno-Oncology Forecast by Application
11 Key Players Analysis
11.1 Bristol-Myers Squibb
11.1.1 Company Details
11.1.2 Immuno-Oncology Product Offered
11.1.3 Bristol-Myers Squibb Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Bristol-Myers Squibb News
11.2 Merck & Co., Inc.
11.2.1 Company Details
11.2.2 Immuno-Oncology Product Offered
11.2.3 Merck & Co., Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Merck & Co., Inc. News
11.3 AstraZeneca, Plc
11.3.1 Company Details
11.3.2 Immuno-Oncology Product Offered
11.3.3 AstraZeneca, Plc Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 AstraZeneca, Plc News
11.4 Sanofi S.A.
11.4.1 Company Details
11.4.2 Immuno-Oncology Product Offered
11.4.3 Sanofi S.A. Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Sanofi S.A. News
11.5 Roche AG
11.5.1 Company Details
11.5.2 Immuno-Oncology Product Offered
11.5.3 Roche AG Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Roche AG News
11.6 Gilead Sciences Inc.
11.6.1 Company Details
11.6.2 Immuno-Oncology Product Offered
11.6.3 Gilead Sciences Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Gilead Sciences Inc. News
11.7 Dendreon Pharmaceuticals
11.7.1 Company Details
11.7.2 Immuno-Oncology Product Offered
11.7.3 Dendreon Pharmaceuticals Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Dendreon Pharmaceuticals News
11.8 Merck KGaA
11.8.1 Company Details
11.8.2 Immuno-Oncology Product Offered
11.8.3 Merck KGaA Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Merck KGaA News
11.9 Novartis
11.9.1 Company Details
11.9.2 Immuno-Oncology Product Offered
11.9.3 Novartis Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Novartis News
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Immuno-Oncology Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Immune Checkpoint Inhibitors
Table 5. Major Players of Cytokine-Based Immunotherapy
Table 6. Major Players of Cancer Vaccines
Table 7. Major Players of CAR-T Cell Therapy
Table 8. Major Players of Others
Table 9. Immuno-Oncology Market Size by Type (2014-2019) ($ Millions)
Table 10. Global Immuno-Oncology Market Size Market Share by Type (2015-2020)
Table 11. Global Immuno-Oncology Market Size by Application (2015-2020) ($ Millions)
Table 12. Global Immuno-Oncology Market Size Market Share by Application (2015-2020)
Table 13. Global Immuno-Oncology Revenue by Players (2018-2020) ($ Millions)
Table 14. Global Immuno-Oncology Revenue Market Share by Players (2018-2020)
Table 15. Global Immuno-Oncology Key Players Head office and Products Offered
Table 16. Immuno-Oncology Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Immuno-Oncology Market Size by Regions 2015-2020 ($ Millions)
Table 20. Global Immuno-Oncology Market Size Market Share by Regions 2015-2020
Table 21. Americas Immuno-Oncology Market Size by Countries (2015-2020) ($ Millions)
Table 22. Americas Immuno-Oncology Market Size Market Share by Countries (2015-2020)
Table 23. Americas Immuno-Oncology Market Size by Type (2015-2020) ($ Millions)
Table 24. Americas Immuno-Oncology Market Size Market Share by Type (2015-2020)
Table 25. Americas Immuno-Oncology Market Size by Application (2015-2020) ($ Millions)
Table 26. Americas Immuno-Oncology Market Size Market Share by Application (2015-2020)
Table 27. APAC Immuno-Oncology Market Size by Regions (2015-2020) ($ Millions)
Table 28. APAC Immuno-Oncology Market Size Market Share by Regions (2015-2020)
Table 29. APAC Immuno-Oncology Market Size by Type (2015-2020) ($ Millions)
Table 30. APAC Immuno-Oncology Market Size Market Share by Type (2015-2020)
Table 31. APAC Immuno-Oncology Market Size by Application (2015-2020) ($ Millions)
Table 32. APAC Immuno-Oncology Market Size Market Share by Application (2015-2020)
Table 33. Europe Immuno-Oncology Market Size by Countries (2015-2020) ($ Millions)
Table 34. Europe Immuno-Oncology Market Size Market Share by Countries (2015-2020)
Table 35. Europe Immuno-Oncology Market Size by Type (2015-2020) ($ Millions)
Table 36. Europe Immuno-Oncology Market Size Market Share by Type (2015-2020)
Table 37. Europe Immuno-Oncology Market Size by Application (2015-2020) ($ Millions)
Table 38. Europe Immuno-Oncology Market Size Market Share by Application (2015-2020)
Table 39. Middle East & Africa Immuno-Oncology Market Size by Countries (2015-2020) ($ Millions)
Table 40. Middle East & Africa Immuno-Oncology Market Size Market Share by Countries (2015-2020)
Table 41. Middle East & Africa Immuno-Oncology Market Size by Type (2015-2020) ($ Millions)
Table 42. Middle East & Africa Immuno-Oncology Market Size Market Share by Type (2015-2020)
Table 43. Middle East & Africa Immuno-Oncology Market Size by Application (2015-2020) ($ Millions)
Table 44. Middle East & Africa Immuno-Oncology Market Size Market Share by Application (2015-2020)
Table 45. Key and Potential Regions of Immuno-Oncology
Table 46. Key Application and Potential Industries of Immuno-Oncology
Table 47. Key Challenges of Immuno-Oncology
Table 48. Key Trends of Immuno-Oncology
Table 49. Global Immuno-Oncology Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 50. Global Immuno-Oncology Market Size Market Share Forecast by Regions
Table 51. Global Immuno-Oncology Market Size Forecast by Type (2021-2025) ($ Millions)
Table 52. Global Immuno-Oncology Market Size Market Share Forecast by Type (2021-2025)
Table 53. Global Immuno-Oncology Market Size Forecast by Application (2021-2025) ($ Millions)
Table 54. Global Immuno-Oncology Market Size Market Share Forecast by Application (2021-2025)
Table 55. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, Immuno-Oncology Major Market Areas and Its Competitors
Table 56. Bristol-Myers Squibb Immuno-Oncology Product Offered
Table 57. Bristol-Myers Squibb Immuno-Oncology Revenue and Gross Margin (2018-2020E)
Table 58. Bristol-Myers Squibb Main Business
Table 59. Bristol-Myers Squibb Latest Developments
Table 60. Merck & Co., Inc. Details, Company Total Revenue (in $ million), Head Office, Immuno-Oncology Major Market Areas and Its Competitors
Table 61. Merck & Co., Inc. Immuno-Oncology Product Offered
Table 62. Merck & Co., Inc. Main Business
Table 63. Merck & Co., Inc. Immuno-Oncology Revenue and Gross Margin (2018-2020E)
Table 64. Merck & Co., Inc. Latest Developments
Table 65. AstraZeneca, Plc Details, Company Total Revenue (in $ million), Head Office, Immuno-Oncology Major Market Areas and Its Competitors
Table 66. AstraZeneca, Plc Immuno-Oncology Product Offered
Table 67. AstraZeneca, Plc Main Business
Table 68. AstraZeneca, Plc Immuno-Oncology Revenue and Gross Margin (2018-2020E)
Table 69. AstraZeneca, Plc Latest Developments
Table 70. Sanofi S.A. Details, Company Total Revenue (in $ million), Head Office, Immuno-Oncology Major Market Areas and Its Competitors
Table 71. Sanofi S.A. Immuno-Oncology Product Offered
Table 72. Sanofi S.A. Main Business
Table 73. Sanofi S.A. Immuno-Oncology Revenue and Gross Margin (2018-2020E)
Table 74. Sanofi S.A. Latest Developments
Table 75. Roche AG Details, Company Total Revenue (in $ million), Head Office, Immuno-Oncology Major Market Areas and Its Competitors
Table 76. Roche AG Immuno-Oncology Product Offered
Table 77. Roche AG Main Business
Table 78. Roche AG Immuno-Oncology Revenue and Gross Margin (2018-2020E)
Table 79. Roche AG Latest Developments
Table 80. Gilead Sciences Inc. Details, Company Total Revenue (in $ million), Head Office, Immuno-Oncology Major Market Areas and Its Competitors
Table 81. Gilead Sciences Inc. Immuno-Oncology Product Offered
Table 82. Gilead Sciences Inc. Main Business
Table 83. Gilead Sciences Inc. Immuno-Oncology Revenue and Gross Margin (2018-2020E)
Table 84. Gilead Sciences Inc. Latest Developments
Table 85. Dendreon Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Immuno-Oncology Major Market Areas and Its Competitors
Table 86. Dendreon Pharmaceuticals Immuno-Oncology Product Offered
Table 87. Dendreon Pharmaceuticals Main Business
Table 88. Dendreon Pharmaceuticals Immuno-Oncology Revenue and Gross Margin (2018-2020E)
Table 89. Dendreon Pharmaceuticals Latest Developments
Table 90. Merck KGaA Details, Company Total Revenue (in $ million), Head Office, Immuno-Oncology Major Market Areas and Its Competitors
Table 91. Merck KGaA Immuno-Oncology Product Offered
Table 92. Merck KGaA Main Business
Table 93. Merck KGaA Immuno-Oncology Revenue and Gross Margin (2018-2020E)
Table 94. Merck KGaA Latest Developments
Table 95. Novartis Details, Company Total Revenue (in $ million), Head Office, Immuno-Oncology Major Market Areas and Its Competitors
Table 96. Novartis Immuno-Oncology Product Offered
Table 97. Novartis Main Business
Table 98. Novartis Immuno-Oncology Revenue and Gross Margin (2018-2020E)
Table 99. Novartis Latest Developments
List of Figures
Figure 1. Immuno-Oncology Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Immuno-Oncology Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Immuno-Oncology Market Size Market Share by Type (2015-2020)
Figure 5. Global Immune Checkpoint Inhibitors Market Size Growth Rate
Figure 6. Global Cytokine-Based Immunotherapy Market Size Growth Rate
Figure 7. Global Cancer Vaccines Market Size Growth Rate
Figure 8. Global CAR-T Cell Therapy Market Size Growth Rate
Figure 9. Global Others Market Size Growth Rate
Figure 10. Immuno-Oncology in Hospitals
Figure 11. Global Immuno-Oncology Market: Hospitals (2015-2020) ($ Millions)
Figure 12. Immuno-Oncology in Drugstores
Figure 13. Global Immuno-Oncology Market: Drugstores (2015-2020) ($ Millions)
Figure 14. Immuno-Oncology in Others
Figure 15. Global Immuno-Oncology Market: Others (2015-2020) ($ Millions)
Figure 16. Global Others YoY Growth ($ Millions)
Figure 17. Global Immuno-Oncology Market Size Market Share by Application in 2019
Figure 18. Global Immuno-Oncology Market Size Market Share by Regions 2015-2020
Figure 19. Americas Immuno-Oncology Market Size 2015-2020 ($ Millions)
Figure 20. APAC Immuno-Oncology Market Size 2015-2020 ($ Millions)
Figure 21. Europe Immuno-Oncology Market Size 2015-2020 ($ Millions)
Figure 22. Middle East & Africa Immuno-Oncology Market Size 2015-2020 ($ Millions)
Figure 23. Americas Immuno-Oncology Market Size Market Share by Countries in 2019
Figure 24. Americas Immuno-Oncology Market Size Market Share by Type in 2019
Figure 25. Americas Immuno-Oncology Market Size Market Share by Application in 2019
Figure 26. United States Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 27. Canada Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 28. Mexico Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 29. APAC Immuno-Oncology Market Size Market Share by Regions in 2019
Figure 30. APAC Immuno-Oncology Market Size Market Share by Type in 2019
Figure 31. APAC Immuno-Oncology Market Size Market Share by Application in 2019
Figure 32. China Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 33. Japan Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 34. Korea Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 35. Southeast Asia Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 36. India Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 37. Australia Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 38. Europe Immuno-Oncology Market Size Market Share by Countries in 2019
Figure 39. Europe Immuno-Oncology Market Size Market Share by Type in 2019
Figure 40. Europe Immuno-Oncology Market Size Market Share by Application in 2019
Figure 41. Germany Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 42. France Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 43. UK Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 44. Italy Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 45. Russia Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 46. Spain Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 47. Middle East & Africa Immuno-Oncology Market Size Market Share by Countries in 2019
Figure 48. Middle East & Africa Immuno-Oncology Market Size Market Share by Type in 2019
Figure 49. Middle East & Africa Immuno-Oncology Market Size Market Share by Application in 2019
Figure 50. Egypt Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 51. South Africa Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 52. Israel Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 53. Turkey Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 54. GCC Countries Immuno-Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 55. Global Immuno-Oncology arket Size Forecast (2021-2025) ($ Millions)
Figure 56. Americas Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 57. APAC Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 58. Europe Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 59. Middle East & Africa Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 60. United States Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 61. Canada Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 62. Mexico Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 63. Brazil Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 64. China Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 65. Japan Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 66. Korea Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 67. Southeast Asia Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 68. India Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 69. Australia Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 70. Germany Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 71. France Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 72. UK Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 73. Italy Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 74. Russia Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 75. Spain Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 76. Egypt Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 77. South Africa Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 78. Israel Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 79. Turkey Immuno-Oncology Market Size 2021-2025 ($ Millions)
Figure 80. GCC Countries Immuno-Oncology Market Size 2021-2025 ($ Millions)
